Good clinical practice points on the use of acetylcholinesterase inhibitors in myasthenia gravis: Recommendations from the Special Interest Group in Myasthenia Gravis in Asia

被引：0

作者：

Goh, K. J. ^{[1
]}

Umapathi, T. ^{[2
]}

Puvanarajah, S. D. ^{[3
]}

Lo, Y. L. ^{[2
]}

Goh, K. Y. ^{[4
]}

Witoonpanich, R. ^{[5
]}

Chankrachang, S. ^{[6
]}

Misbach, J. ^{[7
]}

Wibowo, B. S. ^{[8
]}

Rosales, R. L. ^{[9
]}

Damian, H. L. F. ^{[10
]}

Chan, K. H. ^{[11
]}

Chiu, H. C. ^{[12
]}

Shahrizaila, N. ^{[1
]}

机构：

[1] Univ Malaya, Kuala Lumpur, Malaysia

[2] Natl Inst Neurosci, Singapore, Singapore

[3] Hosp Kuala Lumpur, Kuala Lumpur, Malaysia

[4] Tan Tock Seng Hosp, Singapore, Singapore

[5] Ramathibodi Hosp, Bangkok, Thailand

[6] Chiang Mai Univ, Chiang Mai, Thailand

[7] CiptoMangunkusumo Hosp Ctr, Jakarta, Indonesia

[8] HUSADA Hosp, Jakarta, Indonesia

[9] Univ Santo, Tomas Hosp, Manila, Philippines

[10] St Lukes Hosp, Manila, Philippines

[11] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China

[12] Shin Kong Wu Ho Su Mem Hosp, Taipei, Taiwan

来源：

NEUROLOGY ASIA | 2009年 / 14卷 / 02期

关键词：

OCULAR MYASTHENIA;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：175 / 176

页数：2

共 50 条

[1] Good clinical practice points on the use of acetylcholinesterase inhibitors in myasthenia gravis: recommendations from a South-East Asian regional special interest group on myasthenia gravis
Goh, K. J.
Umapathi, T.
Puvanarajah, S. D.
Lo, Y. K.
Goh, K. Y.
Witoonpanich, R.
Chankrachang, S.
Misbach, J.
Wibowo, B. S.
Rosales, R. L.
Damian, H. L. F.
Chan, K. H.
Chiu, H. C.
Shahrizaila, N.
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S139 - S140
[2] ACETYLCHOLINESTERASE INHIBITORS IN MYASTHENIA GRAVIS: TO BE OR NOT TO BE?
Punga, Anna Rostedt
Stalberg, Erik
[J]. MUSCLE & NERVE, 2009, 39 (06) : 724 - 728
[3] Myasthenia gravis in clinical practice
Estephan, Eduardo de Paula
Soares Baima, Jose Pedro
Zambon, Antonio Alberto
[J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2022, 80 (05) : 257 - 265
[4] Basic treatment of myasthenia gravis - Acetylcholinesterase inhibitors
Janzen, RWC
[J]. AKTUELLE NEUROLOGIE, 1998, 25 : S42 - S45
[5] The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis
Katz, Natalie K.
Barohn, Richard J.
[J]. NEUROPHARMACOLOGY, 2021, 182
[6] Recommendations for myasthenia gravis clinical trials
Li, Hai-feng
Gao, Xiang
Xie, Yan-chen
[J]. MUSCLE & NERVE, 2013, 47 (01) : 144 - 145
[7] Recommendations for myasthenia gravis clinical trials
Benatar, Michael
Sanders, Donald B.
Burns, Ted M.
Cutter, Gary R.
Guptill, Jeffrey T.
Baggi, Fulvio
Kaminski, Henry J.
Mantegazza, Renato
Meriggioli, Matthew N.
Quan, Joanne
Wolfe, Gil I.
[J]. MUSCLE & NERVE, 2012, 45 (06) : 909 - 917
[8] Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation
Brenner, Talma
Nizri, Eran
Irony-Tur-Sinai, Michal
Hamra-Amitay, Yasmine
Wirguin, Itzhak
[J]. JOURNAL OF NEUROIMMUNOLOGY, 2008, 201 : 121 - 127
[9] Myasthenia gravis - Recommendations for clinical research standards
Jaretzki, A
Barohn, RJ
Ernstoff, RM
Kaminski, HJ
Keesey, JC
Penn, AS
Sanders, DB
[J]. NEUROLOGY, 2000, 55 (01) : 16 - 23
[10] RECOMMENDATIONS FOR MYASTHENIA GRAVIS CLINICAL TRIALS REPLY
Sanders, Donald B.
Benatar, Michael
Burns, Ted M.
Cutter, Gary R.
[J]. MUSCLE & NERVE, 2013, 47 (01) : 145 - 146

← 1 2 3 4 5 →